Who’s Involved

FOLLOWING THROUGHThe Campaign for a Canadian Stem Cell Strategy is a joint effort of the stem cell community, key stakeholders, patient advocates and concerned Canadians.  The Joint Strategy Working Group represents key stakeholders:

coalition-partners

What people say about the Strategy

“For decades, stem cells have been able to replace diseased bone marrow as well as cure leukemia and many other blood cancers. We have learned to harness the potential of stem cells and are now building on what we have learned. Tissue repair and cures for a multitude of diseases are now within reach. The Canadian Strategy can make that possible.”
Denis-Claude Roy
Scientific Director, Maisonneuve-Rosemont Hospital Research Centre
CEO, CellCAN Regenerative Medicine and Cell Therapy Network

We have many of the key pieces in place to build a dynamic stem cell industry that will not only revolutionize medicine but will also create the kind of knowledge-economy jobs and biotech manufacturing base to drive Canadian prosperity in the 21st century.  The Strategy can take Canadian research and commercialization ‎to that next level.”
Michael May
CEO, Centre for Commercialization of Regenerative Medicine

“The promise of stem cells is on the verge of being fulfilled, with new treatments for many chronic diseases. As a health charity leader, I’m excited about the possibilities for new ways of treating — and potentially curing — diabetes and I see the Canadian Stem Cell Strategy as a vehicle to help us get there.”
J. Richard Blickstead
President and CEO, Canadian Diabetes Association

“Canadian scientists are among the world leaders in stem cell research. The Canadian Stem Cell Network was the first of its kind and has played a vital role over the past decade in creating the critical mass needed to drive research toward clinical and commercial applications. We can’t afford to lose this momentum.”
Michael Rudnicki
Scientific Director and CEO, Stem Cell Network

“One of the key strengths of the Strategy is that it brings together the scientists, clinicians, health charities, patients, business people and philanthropists. This is a pan-Canadian effort that spans all disease types. There is a massive group of communities behind the Strategy.”
David Young
Chair, Ontario Bioscience Innovation Organization
CEO, Actium Research Inc.

There are few areas of health research that are as exciting and that hold as much potential for human health and treating diseases as stem cells. Canadians have been at the forefront of stem cell research from its early beginnings to the present day.”
Alan Bernstein
Chair, Board of Directors, Canadian Stem Cell Foundation
President & CEO, Canadian Institute for Advanced Research
Founding President Canadian Institutes of Health Research

“If we have a national strategy we’re going to be far more productive.  In Canada, we can do more with a dollar than virtually any other country in the world.  My sense is that’s why the Canadian Stem Cell Strategy is so critical. If we have the ability to do that – if we have the support – we can produce some particularly spectacular results.”
Carlo Fidani
Chair, Orlando Corporation and noted philanthropist

“From a business perspective, I see stem cells coming into force. They were first isolated in Canada about 50 years ago by Till and McCulloch, and Canada is well-engaged in many areas of research and development. So, the potential is there. But you don’t capture potential if you don’t invest in it. Canada should be moving this forward and taking a leadership role.”
Charlie Fischer
Retired President & CEO of Nexen Inc.

“The Strategy will enable us to align priorities, resources, scientists and ultimately business to get the best stem cell science in the world to the patient as quickly and safely as possible.”
Martha Piper
Interim President and Vice Chancellor, University of British Columbia

“Stem cells hold the key to the future. If we can translate our scientific discoveries into clinical practice we can significantly reduce the toll that disease is taking on people’s lives, make our health care system sustainable and reap economic rewards.”
L. Jacques Ménard
Chair of BMO Nesbitt Burns and President of BMO Financial Group, Québec

“Canadians spend over $200 billion a year on health care. Two thirds of that goes to managing currently incurable diseases. Imagine the impact if we could find new treatments and even cures.  Stem cell research and development is putting us at the tipping point where that is now within reach. It’s clearly time to move forward in a decisive co-ordinated effort and the Stem Cell Strategy is the right vehicle to do it.”
Stephen Snyder
Retired President & CEO, TransAlta Corp and former CEO of GE Canada

The Strategy will accelerate the translation of stem cell research into new therapies like the one I received – the one that gave me my life back. We can better the lives of countless people facing immeasurable challenges. Individuals who deserve a second chance of life – much like my second chance of life.”
Tina Ceroni
Stem cell transplant recipient

“Stem cell science is a futures issue where Canada can be a global leader. It is an area where we are truly strong, have a proud history and in which our smartest rank among the best in the world. We’ve already made good investments in the infrastructure. This is a great opportunity for Canada to lead and succeed.”
David Hennigar
Chair & CEO, Thornridge Holdings

“Because stem cells have such a vast role to play in how we treat heart disease, diabetes and  other diseases, it’s imperative that all of us — scientists, medical professionals, health charity champions, business leaders and philanthropists — work together in a co-ordinated and organized way. The Strategy brings those groups together to address that challenge and produce real results.”
Eric Newell
Chancellor Emeritus, University of Alberta
Retired Chair & CEO, Syncrude Canada Ltd.

As opposed to just asking for more money for research, the Strategy deals with the policy changes that need to be addressed and how the regulatory process will be critical to getting Canada to where we want to be: a world leader in producing new treatments and therapies. It sets out the path Canada needs to follow and the actions we need to take to get us there.”
Gerald Grandey
Retired CEO, Cameco Corporation

“The Strategy bolsters Canada’s competitive advantage in the next wave of regenerative medicine and our ability to create a vibrant stem cell industry that generates skilled jobs, boosts the economy, improves health outcomes and brings new therapies to the clinic.”
Nancy & Jon Love
Founder and Managing Partner, KingSett Capital

“I’m living proof of the tremendous potential that exists with stem cell research. I got a second chance at life. This Strategy will help others like me live free of illness and disease.”
Jennifer Molson
Stem cell transplant recipient

 “We are at an incredibly exciting time in science where our research is leading to new treatments and therapies.”
Janet Rossant
Chief of Research at The Hospital for Sick Children

“I’m proud to be a part of this historic coalition.  The Strategy is ready to move forward and already has received private-sector support. Support from all governments will ensure companies like mine are able to create local jobs and, most importantly, transform stem cell research into tangible products and lifesaving therapies.”
Allen Eaves
Founder and CEO of STEMCELL Technologies Inc.

“Canada has always been a leader in stem cell research. With this Strategy and the infrastructure already in place, we have the capacity to transform health care by helping millions of Canadians through new, life-changing therapies and long-term economic growth.”
James Price
President and CEO of the Canadian Stem Cell Foundation